Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 74.47

-2.1%

Nov 13 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1564)	7/16/2007 4:49:39 PM
From: Jibacoa	Read Replies (2) of 3722

AGEN Is trying to find support at the $2.70 level. bigcharts.marketwatch.com Its 1stQ revenues were up significantly,apparently associated with milestone and manufacturing payments from its QS-21 licensees, & it has continued to trim its losses for 4 consecutive Qs. The stock needs to close above $3.45 in order to start getting off its near term DT & try to test its higher resistance at the May 22 H of $3.74 & the April 16 spike at $5.42 bigcharts.marketwatch.com April 16 was when it presented updated data from a P1/2 on Oncophage in recurrent, high-grade glioma at the meeting of the AANS,showing that Oncophage vaccination was associated with significant tumor-specific immune response in all 12 treated patients from baseline (P <.001) AGEN Needs some more encouraging news before it can test its importance resistance at the $10 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next